Q3FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH Exide Industries Ltd(EIL) Automobile Ancillaries BSE CODE: 500086 NSE CODE: EXIDEIND Bloomberg CODE: EXID IN SENSEX: 23,759 Accumulate Rating as per Midcap 12 months investment period CMP Rs127 TARGET Rs144 RETURN 13% 10 th February 2016 Awaiting for revival in volume. Exide Industries (EIL) is a leader in storage battery business with a market share of 60% in India. Its segment includes automotive and industrial lead acid batteries. EIL s Q3FY16 sales de-grew by 2.2% on a YoY basis which is below our estimates. PAT grew 38% YoY to Rs134Cr. Revenue was subdued due to reduction in inverter volumes by -27% and -7% for Automotive and Industrial. EBITDA margins improved by 380bps YoY to 15.4% due to reduction in lead prices and cost reduction efforts. Replacement volume increased by 5% & 10% YoY for 4W and 2W. The industrial segments (36% of revenue) remain subdued. The prospects depend on economic recovery. Going forward we expect rise in market share from unorganised sector which is currently about 40% through implementation of GST. We revise downward our Revenue and PAT estimate for FY17E by -9% and -11% respectively. We expect the worst has come in the price and maintain our rating at accumulate with a target price of Rs144. Technology & GST Implementation to aid growth EIL capex stands at Rs7bn in FY2016, which is likely to increase to Rs11bn by FY2017. Management has indicated that the spur in the capex of 4.5bn will be used in technology up-gradation that could enable reduction in cost of production. Implementation of GST will accelerate the market share from bringing the unorganized sector to organized sector. The unorganized sector currently constitutes 40% Market share which sells at 20-25% discount to organized players due to evasion of indirect tax. Transition in Inverter batteries Industry Industrial segment which contributes 38% of the total revenue consists of telecom, solar, UPS etc. The segment which has performed really well in H2FY15 will remains subdued for H2FY16 due to slow growth in the telecom sector. Inverter segment which constitutes 22% of revenue is become less in demand due to improved power situation in the country. Flat-plate inverter battery volumes declined 27% in 3Q. Tubular battery volume is also in decline. Current Inverter capacity is fungible and can be used for other applications. EBITDA margins will improve... EBITDA margin for the quarter improved at 380bps due to lower lead prices and favorable product mix. However margin for the full year FY16E is expected to be at 15.4% & 16.1% by FY18, once 1) New technology up gradation is operational by FY18 2) Rebound in OEM and CV segments 3) Lowering of lead prices and 4) Cost saving initiatives. Valuation EIL at CMP is currently trading at P/E of 18.2x and 16.2x on FY16E and FY17E earnings respectively. Using SOTP methodology we value the standalone business at 16x over FY17E EPS which is at a discount of 12.5% to its historical average of 18x. Insurance business which is valued at book value of Rs19 per share has been performing well in the south India and it is now expanding well to northern India. We revised our estimates and maintain Accumulate rating with a target price of Rs 144. Company Data Market Cap (mn) Rs 1,07,950 Enterprise Value (mn) Rs 1,08,126 Outstanding Shares (mn) 850 Free Float (%) 54.0 Dividend Yield (%) 0.8 52 week high (Rs) 200 52 week low (Rs) 116 3m average volume-bse+nse (mn) 2.5 Beta 0.9 Face value Rs 1 Shareholding (%) Q1FY16 Q2FY16 Q3FY16 Promoters 45.99 45.99 45.99 FII s 16.91 15.59 16.64 MFs/Insti 15.71 17.26 18.87 Public 21.39 21.16 18.50 Total 100.0 100.0 100.0 Price Performance 3mth 6mth 1 Year Absolute Return -11.4% -20.1% -31.3% Absolute Sensex -7.5% -14.0% -15.4% Relative Return* -4.2% -7.1% -18.8% *over or under performance to benchmark index 200 175 150 125 100 SOTP Valuation Standalone 125 Insurance business SOTP Based Value Exide May-14 Oct-14 Mar-15 Aug-15 Jan-16 Value Per share Comment 19 Sensex Rebase EPS FY17E Valued at 16x Valued at 1x book value 144 Total Value Saji John Analyst
Quarterly Financials Profit & Loss Account (Rs mn) Q3FY16A Q3FY15A YoY Growth % Q2FY16A QoQ Growth % Sales 15,247 15,587-2.2 17,390-12.3 EBITDA 2,343 1,802 30.0 2,574-34.4 Depreciation 406 352 15.4 383 6.0 EBIT 1,937 1,450 33.6 2,191-11.6 Interest 0.50 7.50-0.10 - Other Income 74.60 12.40 512.6 84.40-646 PBT 1,936 1,442 41.0 2,191-11.6 Tax 671 488 37.5 768-12.6 Reported PAT 1,340 972 37.9 1561-14.2 Adjustment - - - - - Adj PAT 1,340 9,72 37.9 1,561-14.2 No. of shares (mn) 850 850-850 - EPS (Rs) 1.58 1.14 38.6 1.84-14.1 Source: Geojit BNP Paribas Research, Company Data Old estimates New estimates Change % Year / Rsmn FY16E FY17E FY16E FY17E FY16E FY17E Revenue 70,321 79,629 67,520 72,220-3.98-9.30 EBITDA 10,679 12,351 10,020 11,391-6.17-7.77 Margins (%) 15.2 15.5 14.8 15.8-40bps +30bps PAT* 6,272 7,485 5,918 6,651-5.64-11.14 EPS* 7.4 8.8 7.0 7.8-5.41-11.36
Standalone Financials Profit & Loss Account Sales 59,642 68,742 67,521 72,220 82,509 % change -2 15-2 7 14 EBITDA 8,145 9,077 10,020 11,391 13,162 % change 4 11 10 14 16 Depreciation 1,256 1,395 1,577 1,898 2,151 EBIT 6,889 7,682 8,443 9,493 11,011 Interest 12 17 3 5 5 Other Income 353 320 300 300 350 PBT 7,231 7,985 8,740 9,788 11,356 % change -3 10 9 12 16 Tax 2,360 2,526 2,822 3,136 3,657 Tax Rate (%) 33% 32% 32% 32% 32% Reported PAT 4,871 5,459 5,918 6,652 7,699 Adj 0 0 0 0 0 Adj PAT 4,871 5,459 5,918 6,652 7,699 % change -7 12 8 12 16 No. of shares (mn) 850 850 850 850 850 EPS (Rs) 6 6 7 8 9 % change -7 12 8 12 16 DPS (Rs) 2 3 2 2 2 CEPS (Rs) 7 8 9 10 12 Cash flow Net inc. + Depn. 8,487 9,380 10,317 11,686 13,507 Non-cash adj. -2,491-2,678-2,619-2,931-3,402 Changes in W.C 474-3,439 1,757 1,878-413 C.F.O 6,470 3,263 9,455 10,632 9,692 Capital exp. -1,346-3,067-5,246-4,045-4,031 Change in inv. -1,352-1,604 93-1,000-2,180 Other invest.cf -1,645 2,523 0 0 0 C.F - investing -4,343-2,148-5,154-5,045-6,211 Issue of equity 0 0 0 0 0 Issue/repay debt 0 176 0 0-6 Dividends paid -1,661-2,180-1,581-1,581-1,581 Other finance.cf -14-12 -3-5 -5 C.F - Financing -1,675-2,016-1,585-1,586-1,592 Chg. in cash 452-901 2,717 4,001 1,889 Closing cash 1,200 298 3,015 7,016 8,905 Balance Sheet Cash & Bank 1,200 298 3,015 7,016 8,905 A/C receivable 5,166 5,550 5,735 6,332 7,234 Inventories 11,856 15,228 13,215 11,277 12,112 Other Cur. Assets 1,185 2,090 1,489 1,595 1,822 Investments 19,670 18,957 18,864 19,864 22,044 Gross fixed assets 19,826 21,883 26,883 30,883 34,883 Net fixed assets 9,768 10,700 14,139 16,262 18,124 CWIP 510 1,002 1,200 1,200 1,200 Intangible assets 212 203 234 259 276 Def. tax net -1,051-1,259-1,459-1,659-1,910 Other assets 0 0 0 0 0 Total assets 48,516 52,768 56,432 62,145 69,807 Cur. liabilities 8,883 9,258 8,691 9,147 10,402 Provisions 2,318 2,788 2,682 2,869 3,165 Debt funds 0 176 176 176 170 Other liabilities 0 0 0 0 0 Equity capital 850 850 850 850 850 Reserves 36,465 39,696 44,033 49,103 55,220 Total Equity 37,315 40,546 44,883 49,953 56,070 Total liabilities 48,516 52,768 56,432 62,145 69,807 BVPS (Rs) 44 48 53 59 66 Ratios Y.E March (Rs mn) FY14A FY15A FY16E FY17E FY18E Profitably. & Return EBITDA margin (%) 13.7 13.2 14.8 15.8 16.0 EBIT margin (%) 11.6 11.2 12.5 13.1 13.3 Net profit mgn.(%) 8.2 7.9 8.8 9.2 9.3 ROE (%) 13.6 14.0 13.9 14.0 14.5 ROCE (%) 9.3 10.0 9.7 9.8 10.1 W.C & Liquidity Receivables (days) 31.4 28.5 30.5 30.5 30.0 Inventory (days) 109.6 108.6 119.5 97.7 82.1 Payables (days) 79.7 72.7 75.4 71.2 68.6 Current ratio (x) 1.7 1.9 2.1 2.2 2.2 Quick ratio (x) 0.7 0.6 1.0 1.5 1.6 Turnover & Levg. Gross asset T.O (x) 3.1 3.3 2.8 2.5 2.5 Total asset T.O (x) 1.3 1.4 1.2 1.2 1.3 Int. covge. ratio (x) 578.9 460.0 2638.6 1898.6 2202.2 Adj. debt/equity (x) 0.0 0.0 0.0 0.0 0.0 Valuation ratios EV/Sales (x) 1.8 1.6 1.6 1.5 1.3 EV/EBITDA (x) 13.3 11.9 10.8 9.5 8.2 P/E (x) 22.2 19.8 18.2 16.2 14.0 P/BV (x) 2.9 2.7 2.4 2.2 1.9
Recommendation Summary (last 3 years) Dates Rating Target 230 180 130 80 May-11 Nov-11 May-12 Nov-12 May-13 Nov-13 May-14 Nov-14 May-15 Nov-15 1 August 2013 Buy 153 28 October 2013 Accumulate 139 15 January 2014 Accumulate 122 29 April 2014 Accumulate 141 23 July 2014 Accumulate 175 22 October 2014 Accumulate 172 4 February 2015 Accumulate 215 6 May 2015 Accumulate 180 3 December 2015 Accumulate 160 10 February 2015 Accumulate 144 Source: Bloomberg, Geojit BNP Paribas Research Large Cap Stocks; Mid Cap and Small Cap; Buy - Upside is 10% or more. Buy - Upside is 15% or more. Hold - Upside or downside is less than 10%. Accumulate* - Upside between 10% - 15%. Reduce - Downside is 10% or more. Hold - Absolute returns between 0% - 10%. Reduce/Sell - Absolute returns less than 0%. To satisfy regulatory requirements, we attribute Accumulate as Buy and Reduce as Sell. The recommendations are based on 12 month horizon, unless otherwise specified. The investment ratings are on absolute positive/negative return basis. It is possible that due to volatile price fluctuation in the near to medium term, there could be a temporary mismatch to rating. * For reasons of valuations/return/lack of clarity/event we may revisit rating at appropriate time. Please note that the stock always carries the risk of being upgraded to BUY or downgraded to a HOLD, REDUCE or SELL. General Disclosures and Disclaimers CERTIFICATION I, Saji John, author of this Report, hereby certify that all the views expressed in this research report reflect my personal views about any or all of the subject issuer or securities. This report has been prepared by the Research Team of Geojit BNP Paribas Financial Services Limited, hereinafter referred to as GBNPP. COMPANY OVERVIEW Geojit BNP Paribas Financial Services Limited (hereinafter GBNPP), a publically listed company, is engaged in services of retail broking, depository services, portfolio management and marketing investment products including mutual funds, insurance and properties. GBNPP is a SEBI registered Research Entity and as such prepares and shares research data and reports periodically with clients, investors, stake holders and general public in compliance with Securities and Exchange Board of India Act, 1992, Securities And Exchange Board Of India (Research Analysts) Regulations, 2014 and/or any other applicable directives, instructions or guidelines issued by the Regulators from time to time. DISTRIBUTION OF REPORTS This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. GBNPP will not treat the recipients of this report as clients by virtue of their receiving this report. GENERAL REPRESENTATION The research reports do not constitute an offer or solicitation for the purchase or sale of any financial instruments, inducements, promise, guarantee, warranty, or as an official confirmation of any transaction or contractual obligations of any kind. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The information contained herein is from publicly available data or other sources believed to be reliable, but we do not represent that it is accurate or complete and it should not be relied on as such. We have also reviewed the research report for any untrue statements of material facts or any false or misleading information. While we endeavour to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. RISK DISCLOSURE GBNPP and/or its Affiliates and its officers, directors and employees including the analyst/authors shall not be in any way be responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Investors may lose his/her entire investment under certain market conditions so before acting on any advice or recommendation in these material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. This report does not take into account the specific investment objectives, financial situation/circumstances and the particular needs of any specific person who may receive this document. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). The price, volume and income of the investments referred to in this report may fluctuate and investors may realize losses that may exceed their original capital. FUNDAMENTAL DISCLAIMER We have prepared this report based on information believed to be reliable. The recommendations herein are based on 12 month horizon, unless otherwise specified. The investment ratings are on absolute positive/negative return basis. It is possible that due to volatile price fluctuation in the near to medium term, there could be a temporary mismatch to rating. For reasons of valuations/return/lack of clarity/event we may revisit rating at appropriate time. The stocks always carry the risk of being upgraded to buy or downgraded to a hold, reduce or sell. The opinions expressed are subject to change but we have no obligation to tell our clients when our opinions or recommendations change. This report is non-inclusive and does not consider all the information that the recipients may consider material to investments. This report is issued by GBNPP without any liability/undertaking/commitment on the part of itself or
any of its entities. We may have issued or may issue on the companies covered herein, reports, recommendations or information which is contrary to those contained in this report. The projections and forecasts described in this report should be evaluated keeping in mind the fact that these are based on estimates and assumptions and will vary from actual results over a period of time. The actual performance of the companies represented in the report may vary from those projected. These are not scientifically proven to guarantee certain intended results and hence, are not published as a warranty and do not carry any evidentiary value whatsoever. These are not to be relied on in or as contractual, legal or tax advice. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice. JURISDICTION The securities described herein may not be eligible for sale in all jurisdictions or to all categories of investors. The countries in which the companies mentioned in this report are organized may have restrictions on investments, voting rights or dealings in securities by nationals of other countries. Distributing/taking/sending/dispatching/transmitting this document in certain foreign jurisdictions may be restricted by law, and persons into whose possession this document comes should inform themselves about, and observe any such restrictions. Failure to comply with this restriction may constitute a violation of any foreign jurisdiction laws. Foreign currencies denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment. Investors in securities such as ADRs, the value of which are influenced by foreign currencies effectively assume currency risk. REGULATORY DISCLOSURES: GBNPP s Associates consists of privately held companies such as Geojit Technologies Private Limited (GTPL- Software Solutions provider), Geojit Credits Private Limited (GCPL- NBFC Services provider), Geojit Investment Services Limited (GISL- Corporate Agent for Insurance products), Geojit Financial Management Services Private Limited (GFMSL) & Geojit Financial Distribution Private Limited (GFDPL), (Distributors of Insurance and MF Units).In the context of the SEBI Regulations on Research Analysts (2014), GBNPP affirms that we are a SEBI registered Research Entity and in the course of our business as a stock market intermediary, we issue research reports /research analysis etc that are prepared by our Research Analysts. We also affirm and undertake that no disciplinary action has been taken against us or our Analysts in connection with our business activities. In compliance with the above mentioned SEBI Regulations, the following additional disclosures are also provided which may be considered by the reader before making an investment decision: 1. Disclosures regarding Ownership*: GBNPP confirms that: It/its associates have no financial interest or any other material conflict in relation to the subject company (ies) covered herein. It/its associates have no actual beneficial ownership greater than 1% in relation to the subject company (ies) covered herein. Further, the Analyst confirms that: he, his associates and his relatives have no financial interest in the subject company (ies) covered herein, and they have no other material conflict in the subject company. he, his associates and his relatives have no actual/beneficial ownership greater than 1% in the subject company covered 2. Disclosures regarding Compensation: During the past 12 months, GBNPP or its Associates: (a) Have not received any compensation from the subject company; (b) Have not managed or co-managed public offering of securities for the subject company (c) Have not received any compensation for investment banking or merchant banking or brokerage services from the subject company (d) Have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company (e) Have not received any compensation or other benefits from the subject company or third party in connection with the research report (f) The subject company is / was not a client during twelve months preceding the date of distribution of the research report. 3. Disclosure by GBNPP regarding the compensation paid to its Research Analyst: GBNPP hereby confirms that no part of the compensation paid to the persons employed by it as Research Analysts is based on any specific brokerage services or transactions pertaining to trading in securities of companies contained in the Research Reports. 4. Disclosure regarding the Research Analyst s connection with the subject company: It is affirmed that I, Saji John, Research Analyst(s) of GBNPP have not served as an officer, director or employee of the subject company 5. Disclosure regarding Market Making activity: Neither GBNPP/its Analysts have engaged in market making activities for the subject company. Please ensure that you have read the Risk Disclosure Documents for Capital Market and Derivatives Segments as prescribed by the Securities and Exchange Board of India before investing. Geojit BNP Paribas, 34/659-P, Civil Lane Road, Padivattom, Kochi 682024. Toll Free Number: 1800-425-5501 / 1800-103-5501, Paid Number: 91 0484 3911777, Email id: customercare@geojit.com Research Entity SEBI Registration Number: INH200000345